Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Circon/U.S. Surgical

This article was originally published in The Gray Sheet

Executive Summary

Circon/U.S. Surgical: Circon board reappoints President and CEO Richard Auhll to its board of directors. Auhll, who was also reappointed chairman, was ousted by an Oct. 6 shareholder vote which installed two USSC-nominated directors ("The Gray Sheet" Oct. 20, In Brief). USSC's hostile $16.50-per-share bid to acquire Circon, which was rejected in August and previously slated to expire Nov. 25, has been extended to Jan. 15, 1998. Auhll replaces Rudolf Schulte, board member since 1977, who resigned for "health and other personal reasons," Circon states. USSC has filed suit in Delaware chancery court seeking to nullify Auhll's reinstatement ("The Gray Sheet" Sept. 22, In Brief)...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT009185

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel